Navigation Links
Neurocrine Biosciences to Present at the 35th Annual J.P. Morgan Healthcare Conference
Date:1/3/2017

SAN DIEGO, Jan. 3, 2017 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and CEO of Neurocrine Biosciences, will be presenting at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco.

The live presentation takes place on Monday, January 9 at 2:30pm PT (5:30pm ET).  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.  

Listeners are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for one month.

About Neurocrine Biosciences

Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders. The Company's two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc., and INGREZZA (valbenazine or NBI-98854), a vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders. Neurocrine plans to commercialize INGREZZA in the United States upon approval by the FDA.

Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300383511.html


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Neurocrine Biosciences to Present at the 28th Annual Piper Jaffray Healthcare Conference
2. Neurocrine Biosciences to Present at the Barclays Global Healthcare Conference
3. Neurocrine Biosciences Announces the Acceptance of Three Scientific Abstracts for Valbenazine (NBI-98854) at the 68th Annual Meeting of the American Academy of Neurology in Vancouver April 2016
4. Neurocrine Biosciences Announces Conference Call and Webcast to Report Fourth Quarter and Year-End 2015 Results
5. Neurocrine Biosciences to Present at the Leerink Partners 5th Annual Global Healthcare Conference
6. Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor Valbenazine in Children and Adolescents with Tourette Syndrome
7. Neurocrine Announces Successful Completion of Phase Ib T-Force Study of VMAT2 Inhibitor NBI-98854 in Adolescents and Children with Tourette Syndrome
8. Neurocrine Biosciences to Present at Credit Suisses 24th Annual Healthcare Conference
9. Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2015 Results
10. Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor NBI-98854 in Adults with Tourette Syndrome
11. Neurocrine Announces Positive Results from Phase III Kinect 3 Study of NBI-98854 in Tardive Dyskinesia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2020)... ... August 26, 2020 , ... Crossroads Hospice & Palliative ... and CPCO to her name. , That’s thanks to her completion of two ... Certified Professional Compliance Officer (CPCO.) , The CHC is designed to mitigate compliance-related ...
(Date:8/26/2020)... ... August 26, 2020 , ... ... organization devoted to funding innovative lymphoma research and serving the lymphoma community through ... with a special virtual LRF Gala and Charity Auction on Wednesday, Sept. ...
(Date:8/26/2020)... N.J. (PRWEB) , ... August 26, 2020 , ... Sudden pain anywhere in the body ... your back. But is your sudden back pain due to a problem in your spine, ... Atlantic Spine Center. , Low back pain is so prevalent that it’s ...
Breaking Medicine Technology:
(Date:9/3/2020)... ... September 03, 2020 , ... International Dark-Sky Association (IDA) recently ... lot controller. This advanced LED wireless dimming controller, along with the previously IDA ... night sky against light pollution. Leo Smith, the Northeast Regional Director for IDA ...
(Date:9/1/2020)... ... September 01, 2020 , ... KitoTech Medical, a ... note financing, which will be used to accelerate the commercialization of its microMend® ... the company will continue to expand its customer base of healthcare systems as ...
(Date:9/1/2020)... , ... September 01, 2020 , ... ... with specialty fellowship training in aesthetic surgery of the face, breast, and body. ... the only female-owned premier boutique plastic surgery and aesthetic practice in Southwest Florida. ...
(Date:8/31/2020)... ... ... found out your dear friend has cancer? , It’s hard to hear your doctor say ... diagnosis. Once the shock wears off, the questions and fears can be overwhelming. , How ... to help? Words are failing me. I’m scared. I want to DO something. , We’ve ...
(Date:8/31/2020)... ... August 31, 2020 , ... Genesis ... chiropractors, announced today the launch of its integrated, HIPAA compliant, telehealth solution, available ... virtual practice in under 90 seconds. , According to the U.S. Department ...
Breaking Medicine News(10 mins):